Evidence map›Paper›PMID 25767029›Full record

ReviewTrends in endocrinology and metabolism: TEM2015

Emerging roles of GPER in diabetes and atherosclerosis.

Matthias Barton, Eric R Prossnitz

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Trends in endocrinology and metabolism: TEM, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04419727 (Molecular Analysis of Estrogen Receptors in Patients With Peripheral Artery Disease), which is not on this map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04419727 unknown statusnot on this mapstarted 2020, after this paper: background citation

Molecular Analysis of Estrogen Receptors in Patients With Peripheral Artery Disease

TypeobservationalSponsorUniversity of CatanzaroRan2020 to 2020Enrolled40ConditionsEstrogen Deficiency, Peripheral Artery DiseaseArmsarterial reconstructive open surgery
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Sexual dimorphism in the liver.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. The Role of Estrogen Receptors in Cardiovascular Disease.International journal of molecular sciences · 2020
    Review
  20. Sex Hormone-Dependent Physiology and Diseases of Liver.International journal of environmental research and public health · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Matthias BartonMolecular Internal Medicine, University of Zurich, Switzerland. Electronic address: barton@access.uzh.ch.
Eric R ProssnitzDepartment of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87120, USA; UNM Cancer Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87120, USA. Electronic address: eprossnitz@salud.unm.edu.
University of New Mexico · USUniversity of Zurich · CH

Funding

G protein-coupled estrogen receptor GPER and breast carcinogenesisR01CA163890 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI PROSSNITZ, ERIC R · 2012 to 2023
$3.3M
Development of GPR30-Selective LigandsR01CA127731 · NCI · UNIVERSITY OF NEW MEXICO · PI ARTERBURN, JEFFREY B, OPREA, TUDOR I · 2008 to 2012
$1.7M
A novel intracellular 7TM estrogen receptor in breastR01CA116662 · NCI · UNIVERSITY OF NEW MEXICO · PI PROSSNITZ, ERIC R · 2006 to 2010
$1.3M
The Role of GPR30 in Advanced Endometrial CancerR01CA118743 · NCI · UNIVERSITY OF NEW MEXICO · PI PROSSNITZ, ERIC R · 2007 to 2009
$855k
NCI NIH HHS CA116662NCI NIH HHS CA118743NCI NIH HHS CA127731NCI NIH HHS CA163890NCI NIH HHS R01 CA116662NCI NIH HHS R01 CA118743NCI NIH HHS R01 CA127731NCI NIH HHS R01 CA163890
6 · The paper itself

Abstract

The G protein-coupled estrogen receptor (GPER) is a 7-transmembrane receptor implicated in rapid estrogen signaling. Originally cloned from vascular endothelial cells, GPER plays a central role in the regulation of vascular tone and cell growth as well as lipid and glucose homeostasis. This review highlights our knowledge of the physiological and pathophysiological functions of GPER in the pancreas, peripheral and immune tissues, and the arterial vasculature. Recent findings on its roles in obesity, diabetes, and atherosclerosis, including GPER-dependent regulation of lipid metabolism and inflammation, are presented. The therapeutic potential of targeting GPER-dependent pathways in chronic diseases such as coronary artery disease and diabetes and in the context of menopause is also discussed.

Indexed as

Lipid MetabolismModels, BiologicalSignal TransductionAnimalsAnti-Obesity AgentsAtherosclerosisCardiovascular AgentsDiabetes MellitusHumansHypoglycemic AgentsLigandsMolecular Targeted TherapyObesityOrgan SpecificityReceptors, EstrogenReceptors, G-Protein-CoupledAnti-Obesity AgentsCardiovascular AgentsGPER1 protein, humanHypoglycemic AgentsLigandsReceptors, EstrogenReceptors, G-Protein-Coupledatherosclerosisdiabetesestrogen receptorGPERrapid signaling

Identifiers

PMID25767029
PMCPMC4731095
OpenAlexW2073242222

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.